Opinion
Video
Focusing on elacestrant, Dr Graff discusses the role of oral SERDs (selective estrogen receptor degraders) in the treatment of patients with ER+/HER2- metastatic breast cancer.
Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?